BEIJING - China's drug safety watchdog Friday ordered a survey over exports of active pharmaceutical ingredients (API) by the country's chemical pharmaceutical manufacturers.
The State Food and Drug Administration said firms need to report names, license numbers and major export destinations of their API, and whether they have got a European certificate for good manufacturing practice.
China is the world's biggest exporter and second largest producer of API.
In China, chemical engineering enterprises can sell their chemical ingredients products as API without approval from drug safety authorities, which puts drug safety under possible risks.
Related Reading:
Fake Chinese malaria drug claims false
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263 Registration Number: 130349 
